Quadria Capital completed a $100m investment in Aragen.

Quadria Capital, a healthcare-focused private equity firm, completed a $100m investment in Aragen, a research and development partner. “We are delighted to welcome Quadria to Aragen. This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market. Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing services, and, most importantly, help our customers accelerate their programs to market faster and more efficiently," Manni Kantipudi, Aragen CEO.